Related Experiment Video
Updated: Feb 4, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer
Haoran Feng1,2, Xi Cheng1,2, Jie Kuang1,2
1Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.
Abstract:
Apatinib, an inhibitor of vascular endothelial growth factor receptor-2, has been shown to promote anti-cancer action across a wide range of malignancies, including gastric, lung, and breast cancers. Our previous study showed that apatinib increases apoptosis in anaplastic thyroid carcinoma (ATC), but the direct functional mechanism of tumor lethality mediated by apatinib is still unknown. In this study, we demonstrated that apatinib induced both autophagy and apoptosis in human ATC cells through downregulation of p-AKT and p-mTOR signals via the AKT/mTOR pathway. Moreover, inhibition of apatinib-induced autophagy increased apatinib-induced apoptosis in ATC cells, and additional tumor suppression was critically produced by the combination of apatinib and the autophagy inhibitor chloroquine in vivo and in vitro. These findings showed that both autophagy and AKT/mTOR signals were engaged in ATC cell death evoked by apatinib. ATC patients might benefit from the new anti-cancer drug, and molecular targeted treatment in combination with autophagy inhibitors shows promise as a treatment improvement.
Insights
Apatinib triggers both autophagy and apoptosis in anaplastic thyroid carcinoma (ATC) by impacting the AKT/mTOR pathway. Combining apatinib with autophagy inhibitors enhances tumor suppression, offering a promising new treatment strategy for ATC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Apatinib, a VEGFR-2 inhibitor, shows anti-cancer effects in various malignancies.
- Previous research indicated apatinib induces apoptosis in anaplastic thyroid carcinoma (ATC).
- The precise mechanism of apatinib's tumor-lethal action in ATC remains unclear.
Purpose of the Study:
- To elucidate the direct functional mechanism of apatinib-induced tumor lethality in human ATC cells.
- To investigate the roles of autophagy and the AKT/mTOR pathway in apatinib's anti-cancer effects on ATC.
Main Methods:
- Investigated apatinib's effects on autophagy and apoptosis in human ATC cells.
- Analyzed the involvement of the AKT/mTOR pathway, including p-AKT and p-mTOR signaling.
- Evaluated the impact of inhibiting apatinib-induced autophagy on apoptosis and tumor suppression in vitro and in vivo, using chloroquine as an autophagy inhibitor.
Main Results:
- Apatinib induced both autophagy and apoptosis in human ATC cells.
- This induction was mediated by the downregulation of p-AKT and p-mTOR via the AKT/mTOR pathway.
- Inhibiting autophagy enhanced apatinib-induced apoptosis, and the combination of apatinib with chloroquine significantly improved tumor suppression.
Conclusions:
- Autophagy and AKT/mTOR signaling are crucial in apatinib-mediated ATC cell death.
- Targeted molecular therapy combining apatinib with autophagy inhibitors presents a promising strategy for improving ATC treatment.
- Anaplastic thyroid carcinoma patients may benefit from apatinib as a novel anti-cancer therapeutic agent.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Apoptosis
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Mechanisms of Retrovirus-induced Cancers

